ATE185150T1 - Proteinkomplex - Google Patents

Proteinkomplex

Info

Publication number
ATE185150T1
ATE185150T1 AT90906389T AT90906389T ATE185150T1 AT E185150 T1 ATE185150 T1 AT E185150T1 AT 90906389 T AT90906389 T AT 90906389T AT 90906389 T AT90906389 T AT 90906389T AT E185150 T1 ATE185150 T1 AT E185150T1
Authority
AT
Austria
Prior art keywords
macromolecule
protein complex
sperm
assay
purification
Prior art date
Application number
AT90906389T
Other languages
English (en)
Inventor
Eva Akerloef
Ake Pousette
Original Assignee
Applied Research Systems
Eva Akerloef
Ake Pousette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems, Eva Akerloef, Ake Pousette filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE185150T1 publication Critical patent/ATE185150T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90906389T 1989-03-31 1990-04-02 Proteinkomplex ATE185150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901127A SE8901127D0 (sv) 1989-03-31 1989-03-31 Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras

Publications (1)

Publication Number Publication Date
ATE185150T1 true ATE185150T1 (de) 1999-10-15

Family

ID=20375510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906389T ATE185150T1 (de) 1989-03-31 1990-04-02 Proteinkomplex

Country Status (10)

Country Link
US (2) US5304464A (de)
EP (2) EP0474645B1 (de)
JP (1) JP2886979B2 (de)
AT (1) ATE185150T1 (de)
AU (1) AU635258B2 (de)
DE (1) DE69033306T2 (de)
DK (1) DK0474645T3 (de)
ES (1) ES2139568T3 (de)
SE (1) SE8901127D0 (de)
WO (1) WO1990012032A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
WO1992010760A1 (en) * 1990-11-30 1992-06-25 Monoclonetics International, Incorporated Methods for the diagnosis of chronic lower back and cervical pain
JP2001504831A (ja) * 1996-11-21 2001-04-10 プロメガ・コーポレーション アルキルペプチドアミドおよび適用
EP0939085A1 (de) 1998-02-26 1999-09-01 Council of Scientific and Industrial Research Verfahren zur Reinigung eines beweglichkeits-förderndes Proteins aus Büffelserum
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
HUE038401T2 (hu) 2014-09-19 2018-10-29 Instr Utils De Laboratori Geniul Sl Eljárás sperma minõségének fokozására emlõsökben
CN107998397B (zh) * 2017-12-07 2020-09-04 复旦大学附属华山医院 Emc10蛋白作为生物标志物在诊断男性不育中的应用
JP7360008B2 (ja) 2019-03-22 2023-10-12 日亜化学工業株式会社 精子の運動能力を増加させる方法及び装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339434A (en) * 1981-08-17 1982-07-13 Gametrics Limited Method of increasing the incidence of female offspring
US4511558A (en) * 1983-05-16 1985-04-16 University Patents, Inc. Alpha-lactalbumin contraceptive
SE449003B (sv) * 1985-10-18 1987-03-30 Pharmacia Ab Sett att in vitro avskilja spermier med egen rorelseformaga medelst penetrationsmedium i vilket ingar hyaluronsyrasalt
US4765972A (en) * 1986-04-03 1988-08-23 The United States Of America As Represented By The Department Of Health And Human Services Vinca alkaloid photoactive analogs and their uses
US5059680A (en) * 1986-11-24 1991-10-22 Centocor, Inc. Method of isolating ca 125 antigen
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males

Also Published As

Publication number Publication date
JP2886979B2 (ja) 1999-04-26
SE8901127D0 (sv) 1989-03-31
EP0965595A1 (de) 1999-12-22
DK0474645T3 (da) 2000-03-27
EP0474645A1 (de) 1992-03-18
US5453354A (en) 1995-09-26
AU635258B2 (en) 1993-03-18
JPH04505614A (ja) 1992-10-01
ES2139568T3 (es) 2000-02-16
EP0474645B1 (de) 1999-09-29
DE69033306T2 (de) 2000-04-13
WO1990012032A1 (en) 1990-10-18
DE69033306D1 (de) 1999-11-04
AU5431890A (en) 1990-11-05
US5304464A (en) 1994-04-19

Similar Documents

Publication Publication Date Title
YU49370B (sh) Postupak za pripremanje vakcine protiv lajmske bolesti
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
EP0683234A4 (de) ANTIKÖRPER GEGEN -g(b)-AMYLOID ODER DERIVATE DAVON UND SEINE VERWENDUNG.
ATE150319T1 (de) Behandlung von asthma
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
DE122005000034I1 (de) Verfahren zur Reinigung von waessrigen Extrakten, die allergenische Proteine enthalten, so erhalteneExtrakte und ihre Verwendung.
DE69033306D1 (de) Proteinkomplex
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
DK0585570T3 (da) Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
DK0489771T3 (da) Modificerede humane anti-Rh(D)-antistoffer
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
ATE328088T1 (de) Transketolase-verwandtes protein
ES2076238T3 (es) Adnc que codifica la proteina 9 de placenta (pp9), su aislamiento y utilizacion.
FR2663748B1 (fr) Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee